LTV-HEXIM1 (147-164)[K4,5,6,13,14,15R], LTV-BR (RRR12)

General Information


DRACP ID  DRACP01939

Peptide Name   LTV-HEXIM1 (147-164)[K4,5,6,13,14,15R], LTV-BR (RRR12)

Sequence  LTVSPWYGCGQLGRRRHRRRPSRRRRHW

Sequence Length  28

UniProt ID  O94992 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma 78%Killing=10 µM; 100%Killing=50 µM CellTox cytotoxicity assay 30 min 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01939

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C154H249N65O34S

Absent amino acids  ADEFIKMN

Common amino acids  R

Mass  406888

Pl  12.87

Basic residues  12

Acidic residues  0

Hydrophobic residues  5

Net charge  12

Boman Index  -15093

Hydrophobicity  -180

Aliphatic Index  38.21

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  12490

Absorbance 280nm  462.59

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26734838

Title  Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy

Doi 10.18632/oncotarget.6794

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_12681

DRACP is developed by Dr.Zheng's team.